International Stem Cell Corporation Published Technology for Cartilage Generation in Journal of Tissue Engineering and Regenerative Medicine Technology
May 30, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018
May 22, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research
May 14, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing...
International Stem Cell Corporation Granted Key Patent in US
May 07, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology...
International Stem Cell Corporation to Present Interim Clinical Results at the American Academy of Neurology
April 18, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based...
International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results
April 10, 2018 08:45 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based...
International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results
April 10, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial
March 05, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...
International Stem Cell Corporation is Valued at $33 Million Market Value by Edison Investment Research
January 22, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing...
International Stem Cell Corporation Treated Real Estate Icon Kevin Weeks
January 11, 2018 08:45 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based...